Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BUPROPION for Smoking cessation therapy: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 702 adverse event reports in the FDA FAERS database where BUPROPION was used for Smoking cessation therapy.

Most Reported Side Effects for BUPROPION

Side Effect Reports % Deaths Hosp.
Completed suicide 5,095 14.3% 5,078 1,750
Drug ineffective 3,991 11.2% 157 522
Toxicity to various agents 3,837 10.8% 2,577 1,828
Depression 2,486 7.0% 163 374
Overdose 2,357 6.6% 584 1,546
Headache 2,323 6.5% 119 578
Anxiety 2,145 6.0% 26 653
Intentional overdose 2,103 5.9% 438 1,642
Drug hypersensitivity 1,967 5.5% 110 71
Seizure 1,894 5.3% 231 1,285
Fatigue 1,687 4.7% 137 203
Nausea 1,597 4.5% 37 459
Product substitution issue 1,578 4.4% 0 25
Off label use 1,514 4.3% 141 410
Drug interaction 1,443 4.1% 163 617

Other Indications for BUPROPION

Product used for unknown indication (18,528) Depression (6,165) Anxiety (1,145) Major depression (988) Suicide attempt (739) Bipolar disorder (702) Antidepressant therapy (252) Attention deficit hyperactivity disorder (244) Ex-tobacco user (205) Attention deficit/hyperactivity disorder (192)

Other Drugs Used for Smoking cessation therapy

NICOTINE (16,741) VARENICLINE (9,055) CHANTIX (889) CHAMPIX (116) NICOTROL (51) UNSPECIFIED INGREDIENT (17) NICORETTE (15) ZYBAN (14) NICODERM CQ (12) NICOTINELL TTS (12)

Related Pages

BUPROPION Full Profile All Smoking cessation therapy Drugs BUPROPION Demographics BUPROPION Timeline